GLP-1 weight loss, done as medicine — not a subscription.
Physician-supervised semaglutide and tirzepatide. Same doctor. Same protocol.
A weight loss clinic that treats GLP-1 therapy as the medication it is — with a baseline panel, a real protocol, monthly InBody scans, and a physician who reads every lab. Bellingham patients get semaglutide or tirzepatide compounded to their tolerance, monitored quarterly, and titrated by response — not a stock 16-week ramp that ignores how you actually feel on the drug. This isn't a five-minute telehealth questionnaire. It's a weight loss clinic inside a concierge primary care relationship.
What telehealth GLP-1 leaves out.
The fastest way to lose weight on a GLP-1 is to skip everything that should happen around it. Hims, Ro, Found, and Henry will write you a prescription in five minutes — and that works, sort of, for the months you're on it. What they don't include is the part that determines whether you keep the weight off, and whether the medication is safe for you in the first place.
A real weight loss clinic isn't a portal where you pick a dose and a refill auto-ships. It's a relationship that catches what GLP-1 alone misses — muscle loss, micronutrient drift, the gallbladder ache at month four, the plateau at month seven — and adjusts in time.
- ✓Baseline lipase to screen for pancreatitis risk — skipped by most telehealth providers, mandatory here.
- ✓Thyroid panel before starting — important for patients with personal or family history of medullary thyroid carcinoma.
- ✓Dose titration based on response, not a stock 16-week ramp regardless of how you tolerate it.
- ✓Monthly InBody body composition scans — segmental muscle and fat tracking, so we catch muscle loss before it shows up on the scale. The point of a GLP-1 is fat loss, not just weight loss.
- ✓What happens at month 12 — taper, maintenance dose, off-medication strategy — is part of the protocol, not an afterthought.
In-clinic GLP-1 vs at-home telehealth.
The biggest decision isn't whether to try GLP-1 — it's the form factor. Telehealth is dramatically cheaper. It's also a categorically different clinical product. Here's the honest comparison.
Common questions about GLP-1 therapy at MBM.
How does GLP-1 work for weight loss?
GLP-1 receptor agonists (semaglutide, tirzepatide) mimic a hormone your gut releases after eating. They slow gastric emptying so meals feel filling longer, blunt the post-meal glucose spike that drives hunger hours later, and modulate the brain's food-reward circuitry — so the constant background pull toward food quiets down. Weight loss is the downstream effect of those three mechanisms running at once, not a single 'fat-burning' action. The drugs work; they also stop working the moment you stop taking them, which is why the protocol around the medication — InBody muscle tracking, nutrition targets, dose titration, and a year-out off-ramp plan — matters as much as the prescription.
What's the difference between semaglutide and tirzepatide?
Semaglutide (Ozempic, Wegovy, compounded equivalents) is a GLP-1 receptor agonist — one mechanism. Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist — two mechanisms working together, which is why head-to-head data shows tirzepatide producing roughly 20% body weight loss at 72 weeks versus semaglutide's roughly 15%. Tirzepatide also tends to have a smoother side-effect profile for some patients. That said, semaglutide is more affordable, has a longer safety record, and is often the right starting point. We pick based on your baseline panel, your weight loss goal, side-effect tolerance, and cost — not a flowchart.
How much does GLP-1 therapy cost?
The GLP-1 medications themselves run $300–$700 per month depending on whether you use compounded semaglutide or tirzepatide, the dose you're titrating to, and which pharmacy fills it. The medical management is included with concierge primary care membership at $300 per month — the consultation, baseline panel, monthly InBody scans, dose titration, quarterly re-panel, side-effect management, and the protocol around the drug. Cash-pay weight loss clinics typically charge $200–$400 per month just for the management layer on top of the medication. Telehealth subscriptions like Hims, Ro, and Found run $90–$200 per month but exclude the workup, labs, and physician relationship that determine whether the drug is safe for you and whether you keep the weight off.
What are the side effects?
The most common: nausea (in 40–60% of patients), constipation, diarrhea, gallbladder symptoms, fatigue. Most resolve within the first 4–8 weeks if dosing is titrated correctly — which is why a stock 16-week ramp regardless of how you tolerate the drug is the wrong approach. Serious but rare risks: pancreatitis (which is why baseline lipase is mandatory before starting), gallbladder disease, and a theoretical thyroid concern that requires screening for personal or family history of medullary thyroid carcinoma. Muscle loss is the under-discussed risk — up to 40% of the weight lost on GLP-1s without resistance training and protein targets is lean mass. That's why InBody scanning is monthly here.
How long until I see results?
Most patients see appetite suppression within the first week and visible scale movement by week 4–6 — though the more important measure is body composition, not the scale. InBody data shows whether the weight coming off is fat (good) or muscle (a protocol problem to fix). The full 15–20% body weight loss most patients are aiming for typically takes 9–15 months of consistent titration and protocol adherence. Patients who do this without the protocol — telehealth prescription, no scans, no labs — often plateau early, regain quickly, or lose more muscle than fat. The medication is the easy part; the protocol around it is what makes the results stick.
Ready to talk about GLP-1?
Thirty minutes with Dr. Scribner — no exam, no commitment, no charge. We talk through your goals, your history, and whether GLP-1 therapy in a concierge primary care context is the right fit.